MOMS 2: A Follow-up to the Management of Myelomeningocele Study

Phase two of the Management of Myelomeningocele Study (MOMS 2), sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, is a multicenter study that continues to monitor health outcomes of the children and mothers who participated in the randomized trial. (Learn more about phase one of the MOMS trial.)

The purpose of MOMS 2 is to compare the long-term effects of prenatal surgery and postnatal surgery for myelomeningocele with respect to the child’s adaptive behavior, physical and cognitive function, health and well-being, and the future reproductive health of the mother.

This important follow-up study, continuing through November 2016, will provide valuable insight into the lasting outcomes of prenatal repair versus standard postnatal repair in children 6 to 10 years of age, and provide both clinical teams and families with additional information to make better informed choices about the treatment options available in the future.

Read some of the most recent reports coming out of this ongoing study.

Pregnant Mom and Child

Choosing a Fetal Treatment Center

Know what questions to ask when considering fetal surgery so you can make an informed decision that is right for you and your baby.

Pregnant Mom and Child

What to Expect

From the moment of referral through delivery and postnatal care, your family can expect a supportive experience when you come to us with a diagnosis of a birth defect.